Unknown

Dataset Information

0

4-{[7-(Trifluoro-meth-yl)quinolin-4-yl]amino}-benzene-sulfonamide-ethanol-methanol (1/0.47/0.53).

ABSTRACT: In the title compound, C(16)H(12)F(3)N(3)O(2)S·0.47C(2)H(5)OH·0.53CH(3)OH, the quinoline ring system is approximately planar, with a maximum deviation of 0.035?(3)?Å, and makes a dihedral angle of 52.67?(9)° with the benzene ring. The F atoms of the -CF(3) group are disordered over two orientations, with refined site occupancies of 0.56?(2) and 0.44?(2). A single solvate site is occupied at random by ethanol or methanol, with refined site occupancies of 0.470?(6) and 0.530?(6), respectively. In the crystal, mol-ecules are linked via N-H?O, N-H?N, O-H?O and C-H?O hydrogen bonds, thereby forming sheets lying parallel to (010).

SUBMITTER: Ghorab MM 

PROVIDER: S-EPMC3414320 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

4-{[7-(Trifluoro-meth-yl)quinolin-4-yl]amino}-benzene-sulfonamide-ethanol-methanol (1/0.47/0.53).

Ghorab Mostafa M MM   Al-Said Mansour S MS   Al-Mishari Abdullah A AA   Quah Ching Kheng CK   Fun Hoong-Kun HK  

Acta crystallographica. Section E, Structure reports online 20120710 Pt 8

In the title compound, C(16)H(12)F(3)N(3)O(2)S·0.47C(2)H(5)OH·0.53CH(3)OH, the quinoline ring system is approximately planar, with a maximum deviation of 0.035 (3) Å, and makes a dihedral angle of 52.67 (9)° with the benzene ring. The F atoms of the -CF(3) group are disordered over two orientations, with refined site occupancies of 0.56 (2) and 0.44 (2). A single solvate site is occupied at random by ethanol or methanol, with refined site occupancies of 0.470 (6) and 0.530 (6), respectively. In  ...[more]

Similar Datasets

Unknown 4-(5-Phenyl-3-trifluoro-meth-yl-1H-pyrazol-1--yl)benzene-sulfonamide.
| S-EPMC3200877 | biostudies-other
Unknown Pyridinium 4-(trifluoro-meth-yl)benzene-sulfonate.
| S-EPMC2977346 | biostudies-literature
Unknown Nicotinaldehyde [2,8-bis-(trifluoro-meth-yl)quinolin-4-yl]hydrazone monohydrate.
| S-EPMC3007871 | biostudies-literature
Unknown 4-[(1,3-Dioxoisoindolin-2-yl)meth-yl]benzene-sulfonamide.
| S-EPMC3998451 | biostudies-literature
Unknown Methyl 2-{[2,8-bis-(trifluoro-meth-yl)quinolin-4-yl]-oxy}acetate.
| S-EPMC3051653 | biostudies-literature
Unknown (E)-2-[3-(Trifluoro-meth-yl)phenyl-imino-meth-yl]benzene-1,4-diol.
| S-EPMC2971128 | biostudies-literature
Unknown N-(2-Meth-oxy-phen-yl)benzene-sulfonamide.
| S-EPMC3006884 | biostudies-literature
Unknown N-(4-Meth-oxy-phen-yl)benzene-sulfonamide.
| S-EPMC3051711 | biostudies-literature
Unknown 3,4-Dimeth-oxy-benzaldehyde [2,8-bis-(trifluoro-meth-yl)quinolin-4-yl]hydrazone.
| S-EPMC3006850 | biostudies-literature
Unknown Benzyl 2-{[2,8-bis-(trifluoro-meth-yl)quinolin-4-yl](hy-droxy)meth-yl}piperidine-1-carboxyl-ate.
| S-EPMC3238965 | biostudies-literature